Your browser doesn't support javascript.
loading
A Nursing Pre-Transplant Intervention to Reduce Patients' Uncertainty about Allogeneic Hematopoietic Stem Cell Transplantation.
Nakano, Kimiko; Fujii, Shiro; Fujioka, Ayame; Kimura, Kumi; Abe, Yoshiki; Abe, Masahiro; Yamamoto, Sena; Arao, Harue.
Afiliación
  • Nakano K; Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Fujii S; Department of Hematology, Tokushima University Hospital, Tokushima, Japan.
  • Fujioka A; Cell Therapy Center, Tokushima University Hospital, Tokushima, Japan.
  • Kimura K; Cell Therapy Center, Tokushima University Hospital, Tokushima, Japan.
  • Abe Y; Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Abe M; Department of Hematology, Endocrinology, and Metabolism, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
  • Yamamoto S; Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan.
  • Arao H; Division of Health Sciences, Osaka University Graduate School of Medicine, Osaka, Japan.
Blood Cell Ther ; 7(1): 14-24, 2024 Feb 25.
Article en En | MEDLINE | ID: mdl-38486826
ABSTRACT
Patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT) procedures often experience high levels of uncertainty. In this study, we developed and implemented a nursing intervention program to help patients recognize and reduce pre-transplant uncertainty. This study used a pretest-posttest single-group design without a control group. Eighteen patients undergoing HSCT participated in the intervention program-which included informational support, confirmation that the patients understood the information provided, and emotional support. Outpatients received the intervention at their initial outpatient visits after their procedure dates were determined, while inpatients received it at discharge following their procedures. The Universal Uncertainty in Illness Scale (UUIS), which consists of 26 items and six subscales, was used as the primary outcome measure. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) and the Hospital Anxiety and Depression Scale were used as secondary outcome measures. The sample included 18 individuals (13 male and five female participants; median age, 52 years). Most participants had acute lymphoblastic leukemia and had previously undergone bone marrow transplantations. Following our intervention, the total UUIS score significantly decreased, from 80.83 ± 18.42 before the intervention to 63.06 ± 23.53 afterward (t = 4.98, p < .001). Furthermore, significant post-intervention reductions were observed for all six subscales of the UUIS. There were no significant differences in the functional EORTC QLQ-C30 scale scores; however, the symptom scale showed a significant decrease in fatigue (pre = 35.19 ± 19.53, post = 25.93 ± 17.04, Z = -1.99, p < 0.046) and constipation (pre = 20.37 ± 20.26, post = 7.41 ± 14.26, Z = -2.11, p = 0.035). There were no significant differences in anxiety and depression levels pre- and post-intervention. Overall, the intervention effectively reduced both UUIS total and subscale scores related to pre-HSCT uncertainties. Assessing uncertainty prior to HSCT is vital to assisting patients in coping with the procedure. Nurses not only provide information but also tailor the information to the patients' cognitive abilities, thereby simplifying their understanding of the disease and its treatment.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Blood Cell Ther Año: 2024 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Blood Cell Ther Año: 2024 Tipo del documento: Article País de afiliación: Japón